A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
RCT(01)
Randomized Clinical Trial (01): A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
2 other identifiers
interventional
40
1 country
1
Brief Summary
Cocaine abuse is an unrelenting public-health concern. Behavioral therapies are considered the "standard of care" for reducing cocaine use and preventing relapse. However, even with intense behavioral interventions, rates of relapse to cocaine use are discouragingly high (i.e., 60-95% of patients return to drug use). Novel strategies are urgently needed to improve treatment outcomes for cocaine-use disorders. The overarching goal of this project is to assess the feasibility, acceptability and initial efficacy of an innovative cocaine-based inhibitory-control training procedure. This goal will be accomplished through the conduct of a Stage I pilot trial. Cocaine-dependent participants will be enrolled and randomized to receive inhibitory-control training to cocaine or neutral images (N=20/condition). This proposed intervention, cocaine based inhibitory-control training, will be delivered using an innovative computer program which teaches cocaine abusers to inhibit a pre-potent response to cocaine or neutral cues. The primary hypothesis is the proposed procedures are feasible and acceptable to the participants. Feasibility will be assessed by determining time needed to enroll the target sample; adaptive randomization outcomes; participant attendance, completion and adherence to study procedures. Acceptability will be determined using a Treatment Acceptability Questionnaire. The secondary hypothesis is that participants receiving cocaine-based inhibitory-control training will reduce their drug use to a greater extent than their counterparts in the neutral-image condition. Reduced cocaine use will be demonstrated by fewer positive-urine samples using qualitative urinalysis and a reduction in levels of benzoylecgonine as determined by quantitative urinalysis (i.e., ELISA). The third hypothesis is that participants receiving cocaine-based inhibitory-control training will show improved inhibitory control and neurocognitive functioning relative to their counterparts in the neutral-image condition. Improved inhibitory control, impulsivity and cognitive functioning will be demonstrated using a battery of clinical instruments and laboratory tasks. The proposed research is highly innovative in that it will provide critical information regarding the feasibility, acceptability, initial efficacy of cocaine-based inhibitory-control training to reduce drug use and improve inhibitory control and neurocognitive functioning in cocaine-dependent participants. Cocaine-based inhibitory control training is also easy to administer (i.e., 15 minutes), inexpensive, need not be administered by a clinician, and could easily be incorporated into current behavioral or community-based treatment approaches to enhance sustained abstinence, thereby quickly impacting clinical research and practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 11, 2015
CompletedFirst Posted
Study publicly available on registry
May 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedJune 26, 2018
June 1, 2018
3.1 years
May 11, 2015
June 22, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Stop-Signal Task
Response inhibition and response execution will be measured using a stop-signal paradigm using a choice reaction time task that engages participants in responding to go-signals when stop-signals occasionally inform them to inhibit the response.
8 weeks after study entry
Secondary Outcomes (6)
Retention
8, 9 and 10 weeks after study entry
Recruitment
Three years
Treatment acceptability
8, 9 and 10 weeks after study
Protocol Adherence
Three years
Self-Reported Cocaine Use
7 days
- +1 more secondary outcomes
Study Arms (2)
Cocaine Inhibitory Control Training
EXPERIMENTALThis group will receive active inhibitory control training.
Neutral Inhibitory Control Training
PLACEBO COMPARATORThis group will receive neutral inhibitory control training.
Interventions
Subjects will learn to inhibit responding in the presence of cocaine cues.
Subjects will learn to inhibit responding in the presence of neutral cues.
Eligibility Criteria
You may qualify if:
- Recent cocaine use verified by a cocaine-positive urine sample
- Meet Cocaine Abuse or Dependence criteria, verified by computerized Structured Clinical Interview for DSM-IV (SCID)
- Subjects must be seeking treatment for their cocaine use.
- Subjects must have at least 10% errors in response to cocaine go cues on the ABBA Task at baseline
You may not qualify if:
- History of serious physical or psychiatric disease that would interfere with study participation
- Current physical or psychiatric disease that would interfere with study participation
- Current or past histories of substance abuse or dependence that would interfere with study completion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Kentuckylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40507, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Craig R. Rush, Ph.D.
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 11, 2015
First Posted
May 14, 2015
Study Start
May 1, 2015
Primary Completion
June 1, 2018
Study Completion
June 1, 2018
Last Updated
June 26, 2018
Record last verified: 2018-06